Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-CXCR5 antibodies, derivatives thereof and their uses

Humanized anti-CXCR5 antibodies, derivatives thereof and their uses

US Patent 9815902 · Granted Nov 14, 2017

Estimated economic value: $9,446,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Trispecific binding proteins, methods, and uses thereof2025
Anti-CD38 antibodies and formulations2023
Trispecific binding proteins, methods, and uses thereof2023
Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of u2022
Antibodies that bind IL-4 and/or IL-13 and their uses2022
Anti-CD38 antibodies and methods of use2022
Anti-CEACAM5 antibodies and uses thereof2022
Anti-CD38 antibodies and methods of use2021
Antibodies that bind IL-4 and/or IL-13 and their uses2020
Anti-CEACAM5 antibodies and uses thereof2019
Humanized antibodies specific to the protofibrillar form of the beta-amyloid pep2018
Humanized antibodies specific to the protofibrillar form of the beta-amyloid pep2018